26, North St

Boston,

MA,

USA,

ZIP: 02109

Phone: +16174554188

As more ADCs receive Accelerated Approval and Fast Track Designation, expediting the transition to the clinic becomes a strategic priority for developers. This underscores the growing need of having a manufacturing processes in place to support fast acceleration. Furthermore, as ADCs progress into later stages, establishing a robust process for guarantees product quality at a commercial scale becomes a high priority.

The inaugural ADC Process Development Summit is the ultimate platform to gain a comprehensive knowledge on the distinctive process development challenges unique to ADCs. By uniting 60+ senior executives pioneering the space, this 3-day meeting will equip you with the expertise needed to establish a high-quality process that meets shortened timelines.

Through unravelling key technical insights ranging from, discussing high quality and high yielding conjugation, impurity purification, drug product lyophilization and formulation, and engaging in regulatory discussions, this meet will leave no aspect of ADC Process Development unexplored.

URLs:
Tickets: https://go.evvnt.com/1780569-2?pid=1052
Brochure: https://go.evvnt.com/1780569-3?pid=1052

Prices:
Drug Developer - Full Package: Conference + Workshop Day: USD 4297.00,
Drug Developer - Conference Only: USD 2299.00,
Solution Provider - Full Package: Conference + Workshop Day: USD 5297.00,
Solution Provider - Conference Only: USD 3799.00

Speakers: Laurie Milnar, Principal Research Scientist, AbbVie, Sunny Zhang, Senior Director, Pharmaceutical Development, ADC Therapeutics, Hayley Jackman, Associate Director, CMC Regulatory Affairs, AstraZeneca, Ahmed Bassyouni, Principal Consultant, Bassyouni Consulting, Michael Adamo, Associate Director, Bristol Myers Squibb, Weijun Li, Senior Director, Biologics Analytical Developmen,  Exelixis, Brandon Coyle, Senior Research Scientist II, Purification  Gilead, Christian Lutz, Director, Project Management, Chemistry, Manufacturing and Controls, Heidelberg Pharma Research, Daniel Milano, Senior Director, Process Development, Immunogen, Sagit Hindi, Associate Director, Janssen, Xiaolin Zhang, Associate Principal Scientist, Biologics Process, R and D  Merck and Co, Yogita Krishnamachari, Director, Merck and Co, Philip Kuhl, Distinguished Scientist, Bioconjugation and Chemistry Commercialization, Merck and Co, Vimal Patel, Vice President, Head of CMC, Orum Therapeutics, Megan Long, Manufacturing Purification Manager, Seagen, Anthony Colenburg, Senior Director/Site Head of Quality, Sutro Biopharma